Joshua Weiyuan Wang is the co-founder of PathoVax, a vaccine biotechnology company developing a First-in-class chimeric Human Papillomavirus (HPV) vaccine. He is also a Postdoctoral Fellow Johns Hopkins Medicine. Joshua has also previously worked as an Equity Research Extern at T. Rowe Price. Joshua was awarded the Pathology Young Investigator Award in 2013 and 2014 for Excellence in Translational Research during his Margaret Lee Fellowship at Johns Hopkins School of Medicine. He holds a Bachelor of Science (BSc) degree with First Class Honours, Biology, from Imperial College London, and a Ph.D. in Pathobiology from The Johns Hopkins University. He is 2015 Fellow in the Startup Leadership Program in the DC Chapter.

Fellow since

Sean L. Evans is the the Founder of Cogentis Therapeutics. He is also a Business Development Manager at Johns Hopkins University. He holds a Master of Science (M.S.), Biotechnology degree from the Johns Hopkins University and a Ph.D. in Molecular Microbiology and Immunology from Johns Hopkins Bloomberg School of Public Health. He is 2015 Fellow in the Startup Leadership Program in DC Chapter.

Fellow since